IMAGING PROTOCOLS
    31.
    发明申请
    IMAGING PROTOCOLS 有权
    成像协议

    公开(公告)号:US20100021378A1

    公开(公告)日:2010-01-28

    申请号:US12309479

    申请日:2007-07-19

    Abstract: Protocols for radioimaging an event or disorder are provided. An exemplary protocol comprises a method of radioimaging a myocardial perfusion, the method comprising in sequence: (a) administering to a subject about 3 mCi Tl201 thallous chloride; (b) allowing said subject to rest; (c) radioimaging a heart of said subject; (d) subjecting said subject to a physical stress; (e) administering to said subject at a peak of said physical stress about 20-30 mCi Tc99m sestamibi; and (f) radioimaging said heart of said subject, thereby radioimaging a myocardial perfusion.

    Abstract translation: 提供用于放射成像事件或障碍的协议。 示例性方案包括放射成像心肌灌注的方法,该方法依次包括:(a)向受试者施用约3mCi Tl201硫酸氯化物; (b)允许所述受试者休息; (c)对所述受试者的心脏进行放射成像; (d)使所述受试者受到身体压力; (e)在所述身体应激的峰值处施用约20-30mCi Tc99m sestamibi的所述受试者; 和(f)对所述受试者的所述心脏进行放射成像,从而放射成像心肌灌注。

    Lens system for nuclear medicine gamma ray camera
    33.
    发明授权
    Lens system for nuclear medicine gamma ray camera 有权
    用于核医学伽玛射线相机的镜头系统

    公开(公告)号:US07402813B2

    公开(公告)日:2008-07-22

    申请号:US11610196

    申请日:2006-12-13

    CPC classification number: G01T1/1648 G01T1/249

    Abstract: A gamma ray camera system is provided, which includes a lens system comprising at least one crystal diffraction lens, and a camera. The camera is configured to perform gamma ray imaging of a first region of a volume of interest using the lens system, and perform gamma ray imaging of a second region of the volume of interest without using the lens system. Other embodiments are also described.

    Abstract translation: 提供了一种伽马射线照相机系统,其包括包括至少一个晶体衍射透镜的透镜系统和照相机。 相机被配置为使用透镜系统对感兴趣体积的第一区域进行伽马射线成像,并且在不使用透镜系统的情况下执行感兴趣体积的第二区域的伽马射线成像。 还描述了其它实施例。

    Multi-dimensional image reconstruction
    35.
    发明申请
    Multi-dimensional image reconstruction 有权
    多维图像重建

    公开(公告)号:US20070194241A1

    公开(公告)日:2007-08-23

    申请号:US11656548

    申请日:2007-01-23

    Abstract: Apparatus for radiation based imaging of a non-homogenous target area having distinguishable regions therein, comprises: an imaging unit configured to obtain radiation intensity data from a target region in the spatial dimensions and at least one other dimension, and an image four-dimension analysis unit analyzes the intensity data in the spatial dimension and said at least one other dimension in order to map the distinguishable regions. The system typically detects rates of change over time in signals from radiopharmaceuticals and uses the rates of change to identify the tissues. In a preferred embodiment, two or more radiopharmaceuticals are used, the results of one being used as a constraint on the other.

    Abstract translation: 用于其中具有可区分区域的非均匀目标区域的用于基于辐射的成像的装置包括:成像单元,被配置为从空间维度和至少一个其他维度中的目标区域获得辐射强度数据,以及图像四维分析 单元分析空间维度中的强度数据和所述至少一个其他维度,以便映射可区分的区域。 该系统通常检测来自放射性药物的信号随时间的变化率,并使用变化率来识别组织。 在优选实施方案中,使用两种或更多种放射性药物,一种用于另一种放射性药物的结果。

    Radiopharmaceuticals for diagnosis and therapy
    38.
    发明授权
    Radiopharmaceuticals for diagnosis and therapy 有权
    用于诊断和治疗的放射性药物

    公开(公告)号:US08894974B2

    公开(公告)日:2014-11-25

    申请号:US11747378

    申请日:2007-05-11

    CPC classification number: A61K31/66 A61K49/0004 A61K51/00

    Abstract: A method for treating a human patient is provided, including administering a radiolabeled form of a therapeutic agent to the patient at a first substantially non-therapeutically-effective dose, wherein pharmacological activity of the therapeutic agent is not due to radioactivity of the therapeutic agent. The method also includes determining information related to a biodistribution of the radiolabeled form of the therapeutic agent in the patient by performing a radioimaging procedure on the patient. Responsively to the information, a decision is made whether or not to treat the patient by administering the therapeutic agent to the patient. If the decision is made to treat the patient, the patient is treated by administering the therapeutic agent to the patient at a second therapeutically-effective dose. If the decision is made not to treat the patient, treatment of the patient with the therapeutic agent is withheld. Other embodiments are also described.

    Abstract translation: 提供了一种治疗人类患者的方法,包括以第一基本上非治疗有效的剂量向患者施用放射标记形式的治疗剂,其中治疗剂的药理学活性不是由于治疗剂的放射性。 该方法还包括通过对患者执行放射成像过程来确定与患者的放射标记形式的治疗剂的生物分布有关的信息。 响应于该信息,决定是否通过向患者施用治疗剂来治疗患者。 如果决定治疗患者,则通过以第二治疗有效剂量向患者施用治疗剂来治疗患者。 如果决定不对待病人,则禁止用治疗剂治疗患者。 还描述了其它实施例。

Patent Agency Ranking